The global injection pen market size is expected to reach USD 70.46 Billion at a steady revenue CAGR of 7.2% in 2030, according to latest analysis by Emergen Research. Market revenue growth is primarily driven by factors such as growing number of regulatory approvals and increasing technological advancements in the field. Injection pens are used for inserting medicine or injecting the insulin into patient’s body. These pens generally consists of a medical cartridge (insulin cartridge), disposable pen, needle and dial for measuring the dosage. For instance, reusable smart insulin pen technology is now available that comes with an easy-to-use smartphone app that can assist diabetics better regulate insulin administration. In addition, these are often less expensive, easier to use, as well as provide several benefits and improvements for those who rely on insulin to control their diabetes, hence demand for such new technology is only rising leading to driving market revenue growth.
The global Injection Pen Market report published by Emergen Research assesses the Injection Pen market with regards to market size, market share, revenue growth, key segments, and regional bifurcation. The global Injection Pen market is highly fragmented with numerous players operating on a global and regional level. The companies are engaged in mergers and acquisitions, joint ventures, and collaborations along with product advancements and R&D activities to cater to the growing global demand and gain a robust footing in the market.
The section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Injection Pen market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others. The report also discusses the initiatives taken by the key companies to combat the impact of the COVID-19 pandemic.
The leading market contenders listed in the report are:
Novo Nordisk A/S, BD, Sanofi, Eli Lilly and Company, Merck KGaA, AstraZeneca, F. Hoffmann-La Roche Ltd., Owen Mumford, Sulzer Ltd., and Sun Pharmaceutical Industries Ltd
Emergen Research has segmented the global Injection Pen market on the basis of type, application, end-use, and region:
Segments Covered in this report are:
Type Outlook (Revenue, USD Billion; 2019–2030)
Disposable
Reusable
Therapy Outlook (Revenue, USD Billion; 2019–2030)
Diabetes
Insulin
Glucagon-Like Peptide-1 (GLP-1) Therapy
Growth Hormone Therapy
Osteoporosis
Fertility
Cancer
Autoimmune Diseases
Others
End-Use Outlook (Revenue, USD Billion; 2019–2030)
Home Care Settings
Hospitals & Clinics
The various regions analyzed in the report include:
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Key Objectives of the Report:
Analysis and estimation of the Injection Pen Market size and share for the projected period of 2022-2030
Extensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape
Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Injection Pen Market
Analysis of the growth prospects for the stakeholders and investors through the study of the promising segments
Strategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.